Genetic Testing for Cancer Risk

• Genetic testing for cancer risk looks for inherited gene mutations that raise susceptibility to certain cancers.
• A result can guide proactive health decisions, including tailored screening and prevention strategies.
• People with a strong family history of cancer, or other specific risk factors, are the ones typically advised to consider genetic counseling and testing.
• Results need professional interpretation to understand what a positive, negative, or uncertain finding actually means and what to do next.
• Laboratory accuracy for detecting a known mutation is generally high, but “accuracy” has real limits worth understanding before testing.

Understanding Genetic Testing for Cancer Risk

Genetic testing for cancer risk is a medical test that looks for specific changes, or mutations, in a person’s genes that can raise the likelihood of developing certain cancers. These mutations are inherited from a parent and present in every cell of the body. Unlike a diagnostic test used after cancer is suspected, this kind of testing assesses predisposition before any cancer develops, which is what allows for proactive management.

How the Testing Process Works

The process is fairly straightforward. A healthcare provider collects a small blood or saliva sample, which is sent to a specialized laboratory where DNA is extracted from the cells and analyzed for specific mutations already known to raise cancer risk — changes in the BRCA1 and BRCA2 genes, for example, are well known for raising breast and ovarian cancer risk. From sample collection to result, the process usually takes several weeks.

Common Genes Associated with Cancer

Several genes are routinely included on cancer genetic testing panels because mutations in them meaningfully raise risk. These genes are generally involved in cell growth, DNA repair, or tumor suppression, and losing their normal function raises the likelihood that cancer develops. Commonly tested genes include:

• BRCA1 and BRCA2: linked to a higher risk of breast, ovarian, prostate, and pancreatic cancer, as well as melanoma.
• MLH1, MSH2, MSH6, PMS2, EPCAM: associated with Lynch syndrome, which raises the risk of colorectal, endometrial, ovarian, and other cancers.
• TP53: associated with Li-Fraumeni syndrome, which raises the risk of several cancers, including sarcomas, breast cancer, and brain tumors.
• CDH1: linked to hereditary diffuse gastric cancer and a form of breast cancer.
• PALB2, CHEK2, ATM: also linked to higher breast cancer risk, sometimes alongside a BRCA mutation and sometimes independent of one.

Benefits for Cancer Prevention and Management

Knowing a genetic risk can shift someone from a reactive approach to a proactive one, giving individuals and families information that can guide future health decisions and, potentially, support earlier detection.

Proactive Health Decisions

A central benefit of testing is the ability to act on the information. If a meaningful cancer risk is identified, a person can work with their healthcare providers on a personalized risk-management plan — which might include lifestyle changes, more intensive surveillance, or preventive surgery. Women with a BRCA1/2 mutation, for example, may choose earlier and more frequent mammograms and MRIs, or consider risk-reducing mastectomy or removal of the ovaries. An inherited genetic change is thought to be behind up to roughly a tenth of all cancers, which is part of why identifying these predispositions matters.

Tailored Screening & Prevention

Test results let healthcare providers adjust screening to an individual’s actual risk profile rather than defaulting to general population guidelines — starting earlier, screening more often, or using more sensitive methods. People with Lynch syndrome, for instance, are often advised to begin colonoscopies in their twenties and repeat them every one to two years, well earlier and more frequently than average. The goal is to catch cancer at its earliest, most treatable point, or prevent it altogether.

Who Should Consider Genetic Testing for Cancer?

Deciding who should be tested is an important step, since testing isn’t recommended for everyone. The decision usually rests on personal and family medical history combined with a conversation with a healthcare professional.

Evaluating Family History

A strong family history of cancer is usually the main reason to consider testing. Patterns worth flagging include:

• Multiple relatives on the same side of the family with the same type of cancer.
• Cancer diagnosed at an unusually young age (for example, breast or colorectal cancer before age 50).
• More than one primary cancer in the same person.
• Rare cancers in the family, such as male breast cancer or medullary thyroid cancer.
• An ethnic background linked to a higher prevalence of specific mutations, such as Ashkenazi Jewish ancestry and BRCA mutations.
• A known genetic mutation already identified in a close relative.

The Role of Genetic Counseling

Talking with a genetic counselor before testing is strongly recommended. Genetic counselors are trained specifically in medical genetics and counseling, and they typically help by:

• Assessing personal and family history to judge whether testing makes sense.
• Explaining the potential benefits, risks, and limits of testing.
• Walking through what different results could mean, for the individual and for relatives.
• Supporting the emotional side of an informed decision about whether to test.
• Interpreting results afterward and guiding next steps, including medical management and how to talk with family.

Interpreting Your Genetic Test Results

Genetic test results can be complex, and understanding them usually calls for guidance from a genetic counselor or healthcare provider. Results generally fall into a few main categories, each with different implications.

Understanding Positive, Negative, VUS

• Positive result: an inherited mutation known to raise cancer risk has been found. This means a meaningfully higher likelihood of certain cancers compared with the general population — not that cancer is inevitable.
• Negative result: no known cancer-associated mutation was found in the genes tested. This can be reassuring, but it doesn’t erase all cancer risk, since most cancers are sporadic rather than inherited; it simply means the specific inherited changes that were tested for were not found.
• Variant of uncertain significance (VUS): a gene change was found, but whether it affects cancer risk isn’t yet known. It’s neither classified as benign nor as disease-causing. Most VUS findings are eventually reclassified as benign as research continues, so they typically don’t lead to changes in medical management on their own unless other risk factors are present.

Actionable Steps After Results

Whatever the result, it’s worth careful discussion with a counselor or physician:

• Positive result: work with a healthcare team on a personalized risk-management plan, which may include closer surveillance, risk-reducing medication, or preventive surgery, and consider sharing the finding with close relatives who may also be at risk.
• Negative result: continue with general cancer screening appropriate for age and personal history, since a negative result doesn’t remove baseline risk.
• VUS result: expect no immediate change in medical management based on the VUS alone, along with guidance on any follow-up as research evolves.

Accuracy and Cost of Genetic Testing

Two practical questions come up often with genetic testing: how reliable are the results, and what will it cost?

Factors Affecting Test Accuracy

Modern sequencing is precise, and laboratories that share results must meet federal quality standards. Even so, “accuracy” has a few important nuances:

• Technical accuracy: a lab’s ability to correctly detect the presence or absence of a specific mutation is generally very high, though no single number applies universally across labs and panels.
• Scope of testing: accuracy only covers the genes actually included in a given panel; a mutation in a gene that wasn’t tested won’t be found.
• VUS interpretation: a variant of uncertain significance is accurately detected as a genetic change, but its effect on cancer risk may simply not be known yet — that’s a gap in scientific understanding, not a flaw in the test.
• Predictive value: a positive result raises risk but doesn’t guarantee cancer will develop; a negative result lowers risk from what’s known but can’t guarantee cancer won’t happen, since other factors also contribute.

Genetic testing describes predisposition, not a definitive prediction of the future.

Financial Considerations and Coverage

Cost varies widely depending on how many genes are tested and which laboratory performs it, from a few hundred to several thousand dollars. Several factors shape the out-of-pocket cost:

• Insurance coverage: most health plans cover counseling and testing once it’s judged medically necessary for your situation; confirming the specifics, and any pre-authorization steps, directly with your insurer beforehand is worthwhile.
• Laboratory pricing: costs vary between testing companies, and more comprehensive panels tend to cost more.
• Financial assistance: some testing companies and outreach programs offer subsidized or lower-cost testing for people who are uninsured or underinsured and meet certain criteria.
• Legal protections against misuse of results: a federal law, the Genetic Information Nondiscrimination Act (GINA), stops health insurers and employers from using someone’s genetic test results to set health-plan eligibility, premiums, or hiring decisions. These protections do not extend to life, disability, or long-term care insurance, where coverage decisions can still legally consider genetic information; a few states offer additional safeguards in those areas.

Discussing likely costs and coverage with a healthcare provider and genetic counselor before testing helps avoid unexpected bills.

Frequently Asked Questions

Does a positive genetic test mean I will definitely get cancer?

No. A positive result means an inherited mutation was found that raises the likelihood of certain cancers, not that cancer is guaranteed. Many people with these mutations never develop cancer. The result is meant to inform action — increased surveillance and preventive steps discussed with your healthcare team — rather than to predict an outcome.

How accurate is genetic testing for cancer risk?

Detecting a known, tested-for gene change is generally very reliable with modern sequencing. That said, accuracy is bounded by scope: a test only looks at the genes on its panel, so it won’t catch a mutation elsewhere. A result can also come back as a variant of uncertain significance, meaning a change was found but its effect on cancer risk isn’t yet understood — that calls for monitoring and further research, not a repeat test.

Is genetic testing for cancer risk covered by insurance?

Coverage varies, but health insurance often covers testing that’s considered medically necessary based on personal or family history or a known mutation in a close relative. It’s best to contact your insurance provider directly about coverage limits and any pre-authorization steps. Testing companies also sometimes offer financial assistance or self-pay options for people without coverage. Separately, federal law (GINA) also bars health insurers and employers from using your results against you, though that protection stops short of life, disability, and long-term care insurance.

Sources

• National Cancer Institute – Genetic Testing Fact Sheet
• National Cancer Institute – The Genetics of Cancer
• MedlinePlus Genetics – Lynch Syndrome
• National Human Genome Research Institute – Genetic Discrimination